BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23758329)

  • 1. Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan.
    Bazarian JJ; Blyth BJ; He H; Mookerjee S; Jones C; Kiechle K; Moynihan R; Wojcik SM; Grant WD; Secreti LM; Triner W; Moscati R; Leinhart A; Ellis GL; Khan J
    J Neurotrauma; 2013 Oct; 30(20):1747-54. PubMed ID: 23758329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
    Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
    Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of S100B protein serum measurement in detecting intracranial injury in children with mild head trauma.
    Manzano S; Holzinger IB; Kellenberger CJ; Lacroix L; Klima-Lange D; Hersberger M; La Scala G; Altermatt S; Staubli G
    Emerg Med J; 2016 Jan; 33(1):42-6. PubMed ID: 26283067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study.
    Okonkwo DO; Puffer RC; Puccio AM; Yuh EL; Yue JK; Diaz-Arrastia R; Korley FK; Wang KKW; Sun X; Taylor SR; Mukherjee P; Markowitz AJ; Jain S; Manley GT;
    J Neurotrauma; 2020 Dec; 37(23):2460-2467. PubMed ID: 32854584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of S100B in detecting intracranial injury in elderly patients with mild traumatic brain injury.
    Santing JAL; Hopman JH; Verheul RJ; van der Naalt J; van den Brand CL; Jellema K
    Injury; 2024 Mar; 55(3):111313. PubMed ID: 38219558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of neuropsychological outcome after mild traumatic brain injury using clinical parameters, serum S100B protein and findings on computed tomography.
    Heidari K; Asadollahi S; Jamshidian M; Abrishamchi SN; Nouroozi M
    Brain Inj; 2015; 29(1):33-40. PubMed ID: 25207823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
    Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
    Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
    Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ
    J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical validation of S100B in the management of a mild traumatic brain injury: issues from an interventional cohort of 1449 adult patients.
    Allouchery G; Moustafa F; Roubin J; Pereira B; Schmidt J; Raconnat J; Pic D; Sapin V; Bouvier D
    Clin Chem Lab Med; 2018 Oct; 56(11):1897-1904. PubMed ID: 29924734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum S100B Levels Can Predict Computed Tomography Findings in Paediatric Patients with Mild Head Injury.
    Kelmendi FM; Morina AA; Mekaj AY; Blyta A; Alimehmeti R; Dragusha S; Ahmeti F; Morina Q; Kotori A
    Biomed Res Int; 2018; 2018():6954045. PubMed ID: 29850551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100B protein level for the detection of clinically significant intracranial haemorrhage in patients with mild traumatic brain injury: a subanalysis of a prospective cohort study.
    Blais Lécuyer J; Mercier É; Tardif PA; Archambault PM; Chauny JM; Berthelot S; Frenette J; Perry J; Stiell I; Émond M; Lee J; Lang E; McRae A; Boucher V; Le Sage N
    Emerg Med J; 2021 Apr; 38(4):285-289. PubMed ID: 33355233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100B protein may detect brain death development after severe traumatic brain injury.
    Egea-Guerrero JJ; Murillo-Cabezas F; Gordillo-Escobar E; Rodríguez-Rodríguez A; Enamorado-Enamorado J; Revuelto-Rey J; Pacheco-Sánchez M; León-Justel A; Domínguez-Roldán JM; Vilches-Arenas A
    J Neurotrauma; 2013 Oct; 30(20):1762-9. PubMed ID: 23710646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100B Blood Level Determination for Early Management of Ski-Related Mild Traumatic Brain Injury: A Pilot Study.
    Kahouadji S; Salamin P; Praz L; Coiffier J; Frochaux V; Durif J; Pereira B; Arlettaz L; Oris C; Sapin V; Bouvier D
    Front Neurol; 2020; 11():856. PubMed ID: 32922357
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum S100B determination in the management of pediatric mild traumatic brain injury.
    Bouvier D; Fournier M; Dauphin JB; Amat F; Ughetto S; Labbé A; Sapin V
    Clin Chem; 2012 Jul; 58(7):1116-22. PubMed ID: 22529109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Children and Youth with Mild and Moderate Traumatic Brain Injury, Glial Fibrillary Acidic Protein Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed Tomography.
    Papa L; Mittal MK; Ramirez J; Ramia M; Kirby S; Silvestri S; Giordano P; Weber K; Braga CF; Tan CN; Ameli NJ; Lopez M; Zonfrillo M
    J Neurotrauma; 2016 Jan; 33(1):58-64. PubMed ID: 25752485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
    J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Biomarker S100B and Mild Traumatic Brain Injury: A Meta-analysis.
    Oris C; Pereira B; Durif J; Simon-Pimmel J; Castellani C; Manzano S; Sapin V; Bouvier D
    Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29716980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker S100B in plasma a screening tool for mild traumatic brain injury in an emergency department.
    H Hopman J; A L Santing J; A Foks K; J Verheul R; M van der Linden C; L van den Brand C; Jellema K
    Brain Inj; 2023 Jan; 37(1):47-53. PubMed ID: 36397287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of S100B use in a cohort of Spanish patients with mild traumatic brain injury: a multicentre study.
    Egea-Guerrero JJ; Rodríguez-Rodríguez A; Quintana-Díaz M; Freire-Aragón MD; Raya-Collados D; Hernández-García C; Ortiz-Manzano Á; Vilches-Arenas Á; Díez-Naz A; Guerrero JM; Murillo-Cabezas F
    Brain Inj; 2018; 32(4):459-463. PubMed ID: 29355397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of S100B to predict severity and cranial CT results in children with TBI.
    Babcock L; Byczkowski T; Mookerjee S; Bazarian JJ
    Brain Inj; 2012; 26(11):1372-80. PubMed ID: 22725661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.